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Abstract
Using a chemical cross-linker and gel electrophoresis or a dot blot overlay assay, we studied protein^protein interaction of
STb toxin, a 48-residue amphiphilic polypeptide causing intestinal disorders. For the first time, we report on the
oligomerization property of STb. This enterotoxin forms hexamers and heptamers in a temperature-independent fashion in
presence or absence of its receptor (sulfatide) anchored in a 50-nm liposome or as a free molecule. Full STb structure integrity
is necessary for its oligomerization as this process is not observed under reducing conditions in the presence of
L-mercaptoethanol. STb treatment with tetramethylurea (TMU) and different detergents prevented oligomerization. Site-
directed mutagenesis decreasing overall STb hydrophobicity in the hydrophobic K-helix resulted in the incapacity to form
oligomers. Taken together, these data suggest that the C-terminal hydrophobic K-helix corresponds to the domain of STb^
STb inter-binding where hydrophobic interaction is involved. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The heat-stable toxin b (STb) produced by entero-
toxigenic Escherichia coli (ETEC) causes £uid and
electrolyte intestinal secretions, leading to diarrhea.
STb toxin is synthesized as a 71-amino-acid precur-
sor which undergoes cleavage of the N-terminus sig-
nal sequence (residues 1^23) [1]. This processing re-
sults in a 48-amino-acid polypeptide of 5200 Da
having a pI of 9.6 [2]. The maturation also involves
the formation of disul¢de bridges between Cys-10
and Cys-48 and between Cys-21 and Cys-36, which
are important for the stabilization of the molecule
tertiary structure [3]. In fact, these disul¢de bridges
were shown to be indispensable for enterotoxicity
[4,5]. Nuclear magnetic resonance (NMR) studies
of STb have established a structure having two anti-
parallel O-helix motifs separated by a loop. There is
an amphipathic helicoidal stretch between residues
10 and 22, exposing several polar side chains to the
solvent. Facing it is an hydrophobic helix extending
from residues 38 to 44 (Fig. 1). The glycine-rich loop
contains some amino acids (Lys-22, Lys-23, Arg-29,
Asp-30) that have been demonstrated to be impor-
tant in enterotoxicity by mutagenesis studies [3]. Re-
cently, the sulfatide [Gal(3-SO4)L1Cer], a glycosphin-
golipid, has been identi¢ed as a functional receptor
for STb [6].
Numerous toxins need to form oligomers to act on
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target cells. For example, among pore forming pro-
tein toxins, most of them undergo an oligomerization
step. In some cases, the oligomeric channels are
formed prior to membranal insertion, as for the aero-
lysin toxin of Aeromonas hydrophila [7]. Alterna-
tively, the K-hemolysin of Staphylococcus aureus
oligomerizes once its monomeric forms are inserted
into the membrane [8]. Oligomerization also occurs
for small bacterial peptides such as the 26-residue
amphipathic polypeptide of Staphylococcus aureus
N-toxin which forms at least tetramers in solution
and 6- to 8-mer on lipid binding [9]. In the present
study, we show evidence of STb peptide oligomer
formation where the C-terminal hydrophobic K-helix
sequence, residues 36^48, plays a critical role in oli-
gomerization of STb toxin.
2. Materials and methods
2.1. Oligonucleotide-directed mutagenesis and DNA
sequencing
Oligonucleotide-directed site-speci¢c mutagenesis
was performed using the U.S.E. Mutagenesis kit pur-
chased from Pharmacia Biotech. The mutagenic
primers (Table 1) used to generate point mutation
were synthesized by Gibco BRL. The plasmid
pMal^STb already described [10] served as template
for production of simple and double mutations. All
mutants were con¢rmed by automated sequencing
with the RmalE primer 5P-GTAACGCCAGG-
GTTTTCC-3P at the DNA sequencing core facility
(University of Maine, Orono, USA) by using an ABI
model 373A stretch DNA sequencer.
2.2. Puri¢cation
In order to obtain pure STb mutants and native
STb enterotoxin, the peptides were produced accord-
ing to a previously described method [2]. Brie£y, an
E. coli strain HB101, harboring the plasmid pMal^
STb or plasmid pMal-mutated STb, highly expressed
the fusion protein, MBP^STb or -mutated STb,
under the control of Ptac. Following the recovery
from an osmotic shock, the fusion protein was a⁄n-
ity puri¢ed by using an amylose resin (New England
Biolabs, Mississauga, Ontario, Canada) and cleaved
with the protease factor Xa. The cleaved material
was loaded on a C8 reverse-phase microbore column
(Applied Biosystems) and eluted with an acetonitrile
gradient (model 130A Separation System, Applied
Biosystems). Puri¢ed peptides were lyophilized and
stored at 320‡C. The purity of the toxins was rou-
tinely veri¢ed by N-terminal sequence analysis using
Edman degradation (Applied Biosystems model
470A gas-phase sequencer) as described before [2].
Fig. 1. Amino acid sequence of mature STb enterotoxin. Cys-10
to Lys-23 and Gly-38 to Ala-44 represent, respectively, the
stretch forming the amphipathic K-helix and the hydrophobic
K-helix. Bold letters represent amino acid residues targeted for
mutagenesis.
Table 1
Synthetic est B mutagenic primers used in this study
Mutations Oligonucleotide sequencea
Lys22CAla, Lys23CAla CCCCTAAAAAACCTGCCGCACAACTTTCCTTGGC
Gly31CAla GCTCCAGCAGTAGCATCTCTAACCC
Phe37CLys CCATTATTTGGGCGCCTTTACATGCTCCAGC
Phe37CAsp CCATTATTTGGGCGCCATCACATGCTCCAGC
Ile41CSer GCTGCAACCATCGATTGGGCGCCAAAGC
Met42CSer CCTTTTGCTGCAACGCTTATTTGGGCGCC
Met42CArg CCTTTTGCTGCAACGCGTATTTGGGCGCC
aUnderlined are the changed bases on the antisense strand of the plasmid pMal^STb.
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2.3. Dot blot overlay assay
Various quantities of wild-type and mutated STb
toxins were dotted on Immunodyne membrane (Pall
Biosupport Division, Glen Cove, NY). A⁄nity-puri-
¢ed aprotinin (Sigma) was used as a negative control
to ascertain the speci¢city of the assay. After the
blocking step with 0.3% (w/v) casein in PBS, the
membranes were then incubated with STb^MBP fu-
sion protein (67 Wg/ml) in 2 ml phosphate-bu¡ered
saline (PBS) (0.15 M NaCl, 100 mM phosphate, pH
7.0) 2.5 h at room temperature. The dot blots were
washed three times for 5 min followed by an incuba-
tion with anti-MBP rabbit antiserum diluted 1:10 000
in PBS for 2 h. Following a washing step with PBS,
goat anti-rabbit IgG conjugated to horseradish per-
oxidase 1:2000 in PBS was added and incubated for
1 h. After washing the membrane, color development
was carried out with of the chromogenic substrate
4-chloro-1-naphthol and H2O2 following the method
of Hawkes [11].
2.4. Liposome preparation
Small unilamellar vesicles (SUV) composed of 10%
sulfatide/90% DMPC (dimyristoyl phosphatidyl cho-
line) (w/w) were prepared by mixing 1 mg of the lipid
mixture, drying for 1 h under vacuum. The mix was
suspended in 0.3 ml PBS (10 mM sodium phosphate,
160 mM NaCl, pH 7.0), and after vortex and a 20-s
sonication step, it was then extruded 19 times
through 50-nm polycarbonate membranes (Avestin).
2.5. Chemical cross-linking
Wild-type and mutant STb toxins were cross-
linked using bis(sulfosuccinimidyl) suberate (BS3).
Six-Wg aliquots (1.16 nmol) of STb toxin in PBS
(20 mM sodium phosphate, 0.15 M NaCl, pH 7.5)
were cross-linked using a 25- or 75-fold molar excess
of BS3 in a reaction volume of 8 Wl, with or without
5% L-mercaptoethanol, 0.5 mg/ml sulfatide, 2 mg/ml
sulfatide containing liposome 0.1, and 0.5 M tetra-
methylurea (TMU), 0.5 and 6 mM CHAPS, 0.05%
and 0.5% Triton X-100, or 20 mM n-octylglucoside
(C8Glc). Cross-linking reaction mixes were incubated
for 38 min at room temperature at 4‡C, 37‡C, and
56‡C and then quenched for 15 min by the addition
of 1 M Tris^HCl (pH 7.5) to a ¢nal concentration
30 mM. An equal volume of sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE)
sample bu¡er was added and the solutions were
boiled for 10 min prior to electrophoretic analysis.
2.6. Gel electrophoresis and immunoblotting
SDS^PAGE was carried out using 15% (w/v) re-
solving gels with a 4.13% (w/v) stacking gel. Proteins
separated by SDS^PAGE were transferred for 80 min
at 100 V onto 0.22-Wm nitrocellulose membranes.
Transfer sheets were blocked for 1 h in blocking so-
lution 0.3% (w/v) casein and then incubated for 2 h
with a rabbit polyclonal anti-STb diluted 1:300. Sub-
sequently, immunoblots were washed three times
(5 min each wash) and incubated for 1 h with horse-
radish peroxidase-conjugated antibody (1:2000).
After washing the membranes, the reactive bands
were visualized using 4-chloro-1-naphthol and
H2O2 following the method of Hawkes [11].
3. Results and discussion
3.1. Characterization of the STb oligomers using
SDS^PAGE
Preliminary results from dot overlay assays indi-
cated a possible interaction between immobilized
STb and the fusion marker MBP^STb (data not
shown). When STb was dotted on a casein blocked
Immunodyne membrane and overlaid with MBP^
STb, the STb^STb interaction was revealed with a
monospeci¢c antiserum raised against MBP. How-
ever, this reaction was not observed with puri¢ed
aprotinin, a 6.5 kDa molecule with a pI of 10.5.
Although not related to STb this molecule was
used as a control as it shares a similar molecular
mass and a basic pI. In addition, casein used as a
blocker also did not react with the dotted STb, con-
¢rming the speci¢city of our assay. To further char-
acterize STb^STb interaction, cross-linking experi-
ments were done. Addition of the cross-linker BS3
to STb or STb mutants in solution was performed
in order to reveal the STb^STb oligomerization, if
present. Electrophoretic analysis of STb cross-linking
reactions on SDS^PAGE revealed that a signi¢cant
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percentage of puri¢ed STb peptide in solution
formed oligomers. In Fig. 2 two major bands are
observed with electrophoretic mobilities of approxi-
mately 28 and 32 kDa that could represent hexame-
ric and heptameric molecularity, respectively, mono-
meric STb being 5189 Da. On Western blot, these
two major oligomeric forms appeared to have the
same intensity and prevailed over the monomeric
and other possible stoichiometry. These results are
consistent with the literature as often toxin oligomer
appears to be composed of seven units, such as for
S. aureus K-toxin [12], aerolysin [13,14], and the an-
thrax protective antigen [15,16].
Assuming that the four glycines present in the loop
of STb toxin confer some £exibility, we investigated
if sulfatide, an STb receptor [6], could induce a con-
formational change of STb upon its binding and then
modify the oligomerization pro¢le. Sulfatide, the re-
ceptor, was added in a 4-fold molar excess to the
cross-linking reaction. As observed in Fig. 2, the mi-
gration pattern of the reaction was not a¡ected by
the presence of the receptor. The same result was
observed using the dot blot overlay assay (data not
shown). As mentioned, S. aureus N-toxin molecular-
ity varies if the oligomerization takes place in solu-
tion or bound to a lipid. Therefore, to rule out the
possibility that STb acts in the same way, the cross-
linking reaction was performed in presence of lipo-
somes containing sulfatide. As observed in Fig. 2, no
di¡erences were seen compared to the reaction with-
out liposomes.
Since all the cross-linking experiments were done
with 145 WM STb, we attempted to ¢nd a minimal
concentration of STb able to produce oligomers. Re-
actions were conducted with 46, 57, and 69 WM of
STb. All reactions showed the same pro¢le of oligo-
merization (data not shown). Interestingly, less than
1 WM of STb is needed to elicit a maximum £uid
secretion in mouse and rat intestinal loops, and £uid
secretion and the release of PGE2 in pig requires as
low as 5^10 nM [17,18]. These concentrations of STb
toxin could not be tested because of the limitation of
the blotting detection method. The oligomerization
process observed here could corroborate results ob-
tained by Beausoleil et al. [19]. In their studies of
STb binding kinetics, the curve representing the at-
tachment of increasing amounts (0.3^39 WM) of STb
to sulfatide showed a sigmoidal shape with at least
three plateaus. Usually, this feature indicates a li-
gand^ligand interaction that may be explained by
the oligomerization process, as we now report.
3.2. Formation of oligomers following chemical and
physical treatments
Properly oxidized disul¢de bonds have been shown
to be important for full enterotoxicity [4,5]. To assert
the importance of STb structure integrity for oligo-
Fig. 3. Chemical cross-linking reactions done in the presence of
5% L-mercaptoethanol (21‡C) or in the absence of 5% L-mer-
captoethanol at 4‡C, 21‡C, 37‡C, and 56‡C.
Fig. 2. Oligomerization of STb toxin. Samples were separated
on 15% gel and visualized by Western blot. STb cross-linked in
the presence of a 75-fold molar excess of BS3 (condition used
in all experiments) (lane 1), a 25-fold molar excess of BS3 (lane
2), 0.5 mg/ml sulfatide (lane 3), and 2 mg/ml sulfatide contain-
ing liposome (lane 4).
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merization, the disul¢de bonds were subjected to re-
duction. Upon L-mercaptoethanol treatment, we did
not observe the oligomerization of STb (Fig. 3).
Thus, STb proper tertiary structure is required for
this process to occur. These results could also be
an indication that oligomerization is a necessary
step in the pathogenesis process of STb enterotoxin,
since reduced STb toxin is not toxic possibly due to
its incapacity to form oligomers.
The e¡ect of incubation temperature on the oligo-
merization of STb was also investigated. According
to the migration pro¢le obtained on Western blot
(Fig. 3), no di¡erence was noted when incubation
temperatures of 4‡C, 21‡C, 37‡C, or 56‡C were com-
pared. Considering the pH sensitivity of the cross-
linker used, no experiments were conducted on the
e¡ect of pH on oligomerization.
3.3. E¡ect of TMU and detergents on oligomerization
To assess the role of hydrophobic bonds in oligo-
mer formation, we studied the in£uence of the pres-
ence of the hydrophobic bond-breaking agent TMU
and di¡erent detergents. TMU at a concentration of
100 mM did not inhibit oligomerization whereas at
500 mM TMU totally prevented the formation of
oligomers (Fig. 4). In the presence of 0.5 mM
CHAPS, a zwitterionic detergent, no e¡ect was de-
tected, but when the concentration was increased to
6 mM, STb^STb interaction was impeded. The same
inhibition was obtained when STb was incubated
with 0.05% of the non-ionic detergent Triton X-
100. There was no disruption of hydrophobic bonds
upon treatment with 20 mM octylglucoside (C8Glc),
a mild non-ionic detergent, but formation of 5-mer
and 6-mer seem favored instead of 6-mer and 7-mer.
Overall, when the hydrophobic bonds were altered,
the oligomerization process was either prevented or
the stoichiometry a¡ected.
Altogether the results indicate that the phenome-
non of self-association described for STb seems to
involve a hydrophobic interaction. Usually, the olig-
omer-forming toxins such as aerolysin oligomerize by
polar interaction, allowing a membranal insertion via
their remaining apolar segment [7]. However, our
results suggest that STb behaves more like S. aureus
N-toxin where oligomerization occurs through its
hydrophobic regions. Moreover, in the eventuality
that STb interacts with the membrane, it is not ex-
cluded that STb could oligomerize via polar bonds
following membranal insertion.
3.4. Role of hydrophobic residues in oligomerization
Considering that the C-terminal K-helix of STb
Fig. 5. Oligomerization of di¡erent STb mutants using (A)
chemical cross-linking reaction or (B) the dot blot overlay as-
say. The presence of STb^STb interaction (+) or its absence
(3) were noted.
Fig. 4. E¡ect of TMU and di¡erent detergents on STb oligo-
merization.
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displays the highest level of hydrophobicity, three
major hydrophobic residues pointing the solvent
(Phe-37, Ile-41, and Met-42) were mutated. In addi-
tion, Lys-22, -23, and Gly-31 located in the loop
were changed for alanine. Chemical cross-linking re-
action and dot blot overlay assay were used to assess
a speci¢c role of these amino acid residues and to
con¢rm the hydrophobic contribution in oligomeri-
zation. In these experiments (Fig. 5), mutants with
decreasing hydrophobicity F37D, F37K, I41S,
M42S, and M42R did not form oligomers while mu-
tation of polar residues, K22A^K23A and G31A, did
not alter the capacity to form oligomer. The single
mutations K22A and K23A also abrogated the ca-
pacity to oligomerize (data not shown). These results
provide more evidence that the non-polar domain is
important for oligomerization.
Overall, we have demonstrated the in vitro oligo-
merization of STb toxin. The oligomer formation
appears to be equally distributed as hexamers and
heptamers. Finally, the process relies on hydrophobic
bonds through its C-terminal hydrophobic K-helix,
of which Phe-37, Ile-41, and Met-42 seem responsi-
ble. Further studies will be required to establish more
precisely the number of STb units involved in the
predominant oligomers and whether this arrange-
ment adopts a ring shape or otherwise.
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